Questions and Answers about Polymyalgia Rheumatica and Giant Cell Arteritis
What Are the Symptoms of Polymyalgia Rheumatica?
In addition to the musculoskeletal stiffness mentioned earlier, people with
polymyalgia rheumatica also may have flu-like symptoms, including fever,
weakness, and weight loss.
What Are the Symptoms of Giant Cell Arteritis?
Early symptoms of giant cell arteritis may resemble flu symptoms such as
fatigue, loss of appetite, and fever. Symptoms specifically related to the
inflamed arteries of the head include headaches, pain and tenderness over the
temples, double vision or visual loss, dizziness or problems with coordination,
and balance. Pain may also affect the jaw and tongue, especially when eating,
and opening the mouth wide may become difficult. In rare cases, giant cell
arteritis causes ulceration of the scalp.
Who Is at Risk for These Conditions?
Caucasian women over the age of 50 have the highest risk of
developing polymyalgia rheumatica and giant cell arteritis. While women are
more likely than men to develop the conditions, research suggests that men with
giant cell arteritis are more likely to suffer potentially blinding eye
involvement. Both conditions almost exclusively affect people over the age of
50. The incidence of both peaks between 70 and 80 years of age.
Polymyalgia rheumatica and giant cell arteritis are both quite
common, according to the National Arthritis Data Work Group. In the United
States, it is estimated that 700 per 100,000 people in the general population
over 50 years of age develop polymyalgia rheumatica. An estimated 200 per
100,000 people over 50 years of age develop giant cell arteritis.
How Are Polymyalgia Rheumatica and Giant Cell Arteritis Diagnosed?
A diagnosis of polymyalgia rheumatica is based primarily on the
patient’s medical history and symptoms, and on a physical examination. No
single test is available to definitively diagnose polymyalgia rheumatica.
However, doctors often use lab tests to confirm a diagnosis or rule out other
diagnoses or possible reasons for the patient’s symptoms.
The most typical laboratory finding in people with polymyalgia
rheumatica is an elevated erythrocyte sedimentation rate, commonly referred to
as the sed rate. This test measures inflammation by determining how quickly red
blood cells fall to the bottom of a test tube of unclotted blood. Rapidly
descending cells (an elevated sed rate) indicate inflammation in the body.
While the sed rate measurement is a helpful diagnostic tool, it alone does not
confirm polymyalgia rheumatica. An abnormal result indicates only that tissue
is inflamed, but this is also a symptom of many forms of arthritis and other